Is the A2 Milk share price crash a buying opportunity?

A2 Milk shares just hit a 52-week low. Is it time to pounce?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The A2 Milk Company Ltd (ASX: A2M) share price had a day to forget on Monday.

The infant formula company's shares ended the day over 13% lower at a 52-week low of $4.27.

A man holds his head in his hands, despairing at the bad result he's reading on his computer.

Image source: Getty Images

Why did the A2 Milk share price crash deep into the red?

Investors were hitting the sell button in a panic following the release of the company's FY 2023 results.

Although A2 Milk actually delivered a strong result, its outlook commentary spooked investors and sent them rushing to the exits.

In respect to its result, A2 Milk beat analyst expectations on both revenue and earnings for the 12 months ended 30 June. Analysts at Bell Potter said:

Revenue of NZ$1,593m was up +10% YOY (vs. BPe NZ$1,587m). EBITDA of NZ$219.3m was up +12% YOY (vs BPe of NZ$215.4m). EBITDA ex-MVM was NZ$245.8m (vs. BPe of NZ$234.3m). Underlying NPAT of NZ$155.6m was up +27% YOY (vs. BPe of $147.5m).

However, all that was overshadowed by the aforementioned outlook commentary. Not only did its guidance for FY 2024 fall short of expectations, but management has also walked away from medium-term margin improvement goals. The broker commented:

A2M expects: (1) low single digit revenue growth in FY24e with EBITDA margins broadly consistent with FY24e levels with higher levels of cash conversion; and (2) A2M has retained its medium term target EBITDA of "teens", while stating it is unlikely they can reach the "low-to-mid 20's" in the foreseeable future. Following the result we have downgraded our NPAT forecasts by -6% in FY24e and FY25e.

Is this a buying opportunity?

Despite the A2 Milk share price hitting a 52-week low, Bell Potter continues to sit on the fence with its recommendation.

The broker has retained its hold rating and cut its price target by 15% to $4.85. It concludes:

We expect 1H24 to be challenging given the China label transition and likely disruption as brands exit the market (~35% are yet to receive SAMR approval). However, A2M has grown share in all key measures in a declining market and is well positioned to benefit from China market brand consolidation, stabilising birth rates, and the return of overseas travellers and students to Australia.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Brambles, CBA, and Macquarie shares

Do analysts rate these shares as buys? Let's find out.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »